PETALING JAYA: The National Pharmaceutical Regulatory Agency (NPRA) has only recorded two serious reports involving adverse events following immunisation (AEFI) among children aged between five and 11 years old as of Feb 25.
NPRA director Dr Roshayati Mohamad Sani said these two cases, both aged 10 years old, involved a girl who had existing asthma and a boy with Bell's Palsy or facial paralysis.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
